Testing an herb formula to prevent early stroke worsening
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tests a traditional Chinese herb formula called Qingre Huatan to see if it can stop stroke symptoms from getting worse in the first few days. It is for people who have had an ischemic stroke within the last 48 hours and are at high risk for early decline.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke from a blocked blood vessel in the brain (ischemic stroke) and are in the hospital.
- You meet the Traditional Chinese Medicine criteria for 'phlegm-heat' syndrome.
- You are at high risk for early worsening, meaning an MRI shows new damage, you have a low ASPECTS score, or you have at least two risk factors.
- Your stroke started within the last 48 hours.
- You are between 18 and 80 years old.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether MT200605 can help people who recently had an ischemic stroke (a type of stroke caused by a blocked blood vessel). The drug is given within 24 hours of symptoms starting, and you may join even if you received clot-busting treatment already.
This Phase 2 study tests LT3001 to improve recovery after an acute ischemic stroke (a stroke caused by blocked blood flow). It is designed for people who can be treated within 24 hours of symptom onset and who meet specific safety and health requirements.
This trial tests a Chinese herbal granule (Xinglou Chengqi) given to people hospitalized with a recent ischemic stroke (within 7 days). It looks at whether the medicine can help improve recovery when added to standard care.
This trial tests whether a traditional Chinese medicine (Angong Niuhuang pill) made from different sources of a natural ingredient can help people who recently had a moderate stroke caused by a blood clot. It aims to see if the pill can improve recovery.
This trial tests a traditional Chinese herbal formula, Tanhuo Decoction, for elderly patients who recently had a heart attack (acute coronary syndrome) and also have brain artery narrowing or a history of stroke. It aims to see if the medicine helps improve recovery and reduce future risks.
This study tracks people who had an ischemic stroke (a type of stroke caused by blocked blood flow) within the last week and received Suhexiang Pill. It aims to see how outcomes and follow-up go in real-world use, which may help doctors understand who might benefit and how to monitor patients.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.